215 related articles for article (PubMed ID: 15030337)
1. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
2. Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical Structures.
Maurichi A; Barretta F; Patuzzo R; Sala L; Miceli R; Gallino G; Mattavelli I; Leva A; Simonotti N; Taglione B; Cossa M; Belotti A; Valeri B; Cortinovis U; Santinami M
JAMA Dermatol; 2023 Jun; 159(6):587-595. PubMed ID: 37043209
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.
Sun W; Xu Y; Qu X; Jin Y; Wang C; Yan W; Chen Y
Arch Dermatol Res; 2023 Oct; 315(8):2305-2312. PubMed ID: 36988664
[TBL] [Abstract][Full Text] [Related]
4. Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery.
Tate JA; Matsumoto A; Greif C; Lim J; Nijhawan RI; Srivastava D
J Am Acad Dermatol; 2024 Jun; 90(6):1226-1231. PubMed ID: 38253130
[TBL] [Abstract][Full Text] [Related]
5. Biopsy for malignant melanoma--are we following the guidelines?
Tadiparthi S; Panchani S; Iqbal A
Ann R Coll Surg Engl; 2008 May; 90(4):322-5. PubMed ID: 18492398
[TBL] [Abstract][Full Text] [Related]
6. Deep Margins Melanoma: How Deep Is Deep Enough?
Burger ML; Haggerty JM; Wang S; Oxenberg JC
Am Surg; 2023 Dec; 89(12):5297-5303. PubMed ID: 36530056
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Incipient Ulceration in Primary Cutaneous Melanoma.
Paver EC; Ahmed T; Burke H; Saw RPM; Stretch JR; Spillane AJ; Shannon KF; Vergara IA; Elder DE; Lo SN; Thompson JF; Scolyer RA
JAMA Dermatol; 2023 Dec; 159(12):1359-1367. PubMed ID: 37910123
[TBL] [Abstract][Full Text] [Related]
8. Real-World Outcomes of Inoperable and Metastatic Cutaneous Head and Neck Melanoma Patients.
Rozendorn N; Shutan I; Feinmesser G; Grynberg S; Hodadov H; Alon E; Asher N
Laryngoscope; 2024 Jun; 134(6):2762-2770. PubMed ID: 38230960
[TBL] [Abstract][Full Text] [Related]
9. The impact of prognostic factors and comorbidities on survival in older adults with stage I - III cutaneous melanoma in Southwest Finland: A register study.
Mattila KE; Vihinen H; Heervä E; Nuotio MS; Vihinen P
J Geriatr Oncol; 2024 Mar; 15(2):101701. PubMed ID: 38219332
[TBL] [Abstract][Full Text] [Related]
10. The prognostic importance of scalp location in primary head and neck melanoma.
Ozao-Choy J; Nelson DW; Hiles J; Stern S; Yoon JL; Sim MS; Faries MB
J Surg Oncol; 2017 Sep; 116(3):337-343. PubMed ID: 28543136
[TBL] [Abstract][Full Text] [Related]
11. Surgical margins and outcomes for eyelid melanoma: a systematic review and meta-analysis.
Pisano CE; Trager MH; Fan W; Samie FH
Arch Dermatol Res; 2024 Mar; 316(4):106. PubMed ID: 38489027
[TBL] [Abstract][Full Text] [Related]
12. Analysis of patients diagnosed with primary cutaneous melanoma in the last six years in Hospital Erasto Gaertner: epidemiologic profile.
Foiato TF; Bereza BRK; Montenegro MF; Guilherme MR; Volski LB; Rebolho JC
An Bras Dermatol; 2018 Jun; 93(3):332-336. PubMed ID: 29924232
[TBL] [Abstract][Full Text] [Related]
13. Polo-Like Kinase 4 Correlates with Aggressive Tumor Characteristics, Shortened Disease-Free Survival and Overall Survival in Patients with Cutaneous Melanoma who Undergo Surgical Resection.
Zhang L; Zhang S; Han Z; Liu Z; Xu Y; Li X; Miao G; Niu L
Tohoku J Exp Med; 2024 Apr; 262(4):253-261. PubMed ID: 37940564
[TBL] [Abstract][Full Text] [Related]
14. Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study.
Doniņa S; Strēle I; Proboka G; Auziņš J; Alberts P; Jonsson B; Venskus D; Muceniece A
Melanoma Res; 2015 Oct; 25(5):421-6. PubMed ID: 26193376
[TBL] [Abstract][Full Text] [Related]
15. Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.
Eggermont AMM; Bellomo D; Arias-Mejias SM; Quattrocchi E; Sominidi-Damodaran S; Bridges AG; Lehman JS; Hieken TJ; Jakub JW; Murphree DH; Pittelkow MR; Sluzevich JC; Cappel MA; Bagaria SP; Perniciaro C; Tjien-Fooh FJ; Rentroia-Pacheco B; Wever R; van Vliet MH; Dwarkasing J; Meves A
Eur J Cancer; 2020 Nov; 140():11-18. PubMed ID: 33032086
[TBL] [Abstract][Full Text] [Related]
16. Primary Cutaneous Melanoma-Management in 2024.
Dixon AJ; Sladden M; Zouboulis CC; Popescu CM; Nirenberg A; Steinman HK; Longo C; Dixon ZL; Thomas JM
J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541831
[No Abstract] [Full Text] [Related]
17. Melanoma with rhabdomyosarcomatous features: a potential diagnostic pitfall.
Watter H; Milkins R; Chambers C; O'Brien B
BMJ Case Rep; 2023 Oct; 16(10):. PubMed ID: 37879714
[TBL] [Abstract][Full Text] [Related]
18. Histologic margin status is a predictor of relapse in lentigo maligna melanoma.
Hoang MP; Karpinski P; Zúñiga-Castillo M; Foreman RK; Emerick KS; Sober AJ
J Am Acad Dermatol; 2023 Nov; 89(5):959-966. PubMed ID: 37454699
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic factors in 98 patients with malignant melanoma in China.
Zhang M; Zhang N
J Int Med Res; 2017 Aug; 45(4):1369-1377. PubMed ID: 28587543
[TBL] [Abstract][Full Text] [Related]
20. Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study.
Mezőlaki NE; Baltás E; Ócsai HL; Varga A; Korom I; Varga E; Németh IB; Kis EG; Varga J; Kocsis Á; Gyulai R; Bukva M; Kemény L; Oláh J
Melanoma Res; 2024 Feb; 34(1):54-62. PubMed ID: 37962233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
